ArticleDrug design, development and therapy

Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.

Da-Jin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.